BioReference · 1 month ago
Urology Account Executive (Seattle, WA)
BioReference is a company focused on providing innovative health solutions, and they are seeking a Urology Account Executive to manage and expand their Urology accounts in Seattle, WA. The role involves driving sales, maintaining client relationships, and ensuring compliance while promoting the 4Kscore® Test.
BiotechnologyHealth CareHealth DiagnosticsHospitality
Responsibilities
Drive sales in assigned territory by increasing test utilization of existing accounts, new lead generation, referrals and establishing strong relationships with prospective customers
Target and close new 4Kscore Test opportunities
Provide in field problem resolution for client concerns/questions as needed
Provide subject matter expertise for associated specialty testing
Maintain and pursue knowledge in associated specialist testing area and competitive landscape in the Urology market
Maintain a breadth of knowledge of all connectivity products (i.e. InsightDX)
Ensure compliance with company policies and government regulations
Complete all administrative tasks thoroughly and promptly
Qualification
Required
Bachelor's degree in business or science
Urology market sales experience in the territory
Ability to develop and sustain strong customer relationships
Possess strong planning and organizational skills
Clean, valid driver's license and a vehicle to use for work daily
Effectively manage travel schedule to meet needs of assigned territory and represent company at industry meetings as needed
Preferred
Possess strong planning and organizational skills
Clean, valid driver's license and a vehicle to use for work daily
Effectively manage travel schedule to meet needs of assigned
Solid PC skills including Word, Excel, PowerPoint
Company
BioReference
For more than four decades, BioReference has built a legacy based on scientific excellence, innovation and world-class service in laboratory testing solutions.
Funding
Current Stage
Public CompanyTotal Funding
unknown2015-06-05Acquired
1993-12-03IPO
Leadership Team
M
Marc D. Grodman
CEO
Recent News
2025-10-31
PR Newswire
2025-10-28
Company data provided by crunchbase